

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Alectinib ni umuti wagenewe kurwanya kanseri ufasha kuvura ubwoko bwihariye bwa kanseri y'ibihaha yitwa ALK-positive non-small cell lung cancer. Uyu muti ukora ubu byanga ibintu bimwe na bimwe bifasha selile za kanseri gukura no gukwirakwira, bigaha umubiri wawe amahirwe yo kurwanya indwara neza.
Niba wowe cyangwa umuntu ukwitaho yarandikiwe alectinib, birashoboka ko ufite ibibazo byinshi bijyanye n'uko ikora n'icyo witegura. Reka tunyuremo ibyo ukeneye kumenya byose kuri uyu muti mu magambo asobanutse kandi yoroshye.
Alectinib ni umuti wandikirwa na muganga wo mu itsinda ry'imiti yitwa tyrosine kinase inhibitors. Tekereza nk'ubuvuzi bwagenewe kurwanya selile za kanseri zifite ihinduka ryihariye rya genetike.
Uyu muti wagenewe abantu bafite kanseri y'ibihaha ifite ihinduka ryihariye rya genetike ryitwa ALK rearrangement. Muganga wawe azagerageza selile zawe za kanseri kugirango arebe niba bafite iri hinduka mbere yo kwandika alectinib.
Uyu muti uza mu buryo bwa capsule kandi ufashwe mu kanwa, bituma byoroha kurusha imiti isaba gusura ibitaro kugirango baterwe imiti.
Alectinib yemerejwe by'umwihariko kuvura ALK-positive non-small cell lung cancer. Ubu bwoko bwa kanseri y'ibihaha bugize hafi 3-5% bya kanseri zose z'ibihaha, kandi bikunda kugaragara cyane mu bantu bakiri bato n'abatanywa itabi.
Muganga wawe ashobora kukwandikira alectinib nk'ubuvuzi bwawe bwa mbere niba umaze kuvumburwa ko ufite ubu bwoko bwa kanseri. Irashobora kandi gukoreshwa niba izindi ALK inhibitors zitagukoreye neza cyangwa zahagaze gukora.
Uyu muti ukora neza cyane iyo kanseri yagiye mu bindi bice by'umubiri wawe, harimo n'ubwonko. Ubushakashatsi bwerekana ko bushobora kugabanya ibibyimba no gutinda gukura kwa kanseri.
Alectinib ikora ibi ikingira poroteyine yitwa ALK ifasha selile za kanseri gukura no kwiyongera. Iyo iyi poroteyine ikora cyane bitewe n'imihindagurikire ya jeni, itanga ibimenyetso bituma selile za kanseri zikura vuba.
Mugukingira ibi bimenyetso, alectinib ishyira feri ku mikurire ya kanseri. Ibi biha urwego rwawe rw'ubudahangarwa n'izindi nshingano amahirwe yo kurwanya kanseri neza.
Uyu muti ufatwa nk'umuti ukomeye kandi ufite akamaro mu kuvura kanseri y'ibihaha ya ALK-positive. Abantu benshi babona ibibyimba byabo bigabanuka mu mezi make ya mbere yo kuvurwa.
Fata alectinib nk'uko muganga wawe abikwandikiye, akenshi kabiri ku munsi hamwe n'ibiryo. Kuyifata hamwe n'ifunguro bifasha umubiri wawe gukoresha neza umuti kandi bishobora kugabanya kuribwa mu gifu.
Urashobora gufata alectinib hamwe n'ubwoko ubwo aribwo bwose bw'ibiryo, ariko kuyifata hamwe n'ifunguro ririmo amavuta ashobora gufasha mu kuyikoresha. Ntukibaze ku gihe cyo kuyifata hamwe n'ibiryo byihariye - gusa menya ko utayifata mu gifu cyambaye ubusa.
Mimina ibinini byose hamwe n'amazi. Ntuyifungure, uyikubite, cyangwa uyisye, kuko ibi bishobora kugira ingaruka ku buryo umuti ukora. Niba ugira ikibazo cyo kumira ibinini, ganira na muganga wawe ku bindi bisubizo.
Gerageza gufata imiti yawe ku gihe kimwe buri munsi kugirango ugumane urwego rwawo mu mubiri wawe. Gushyiraho ibyibutsa kuri terefone birashobora kugufasha kwibuka.
Ubusanzwe uzakomeza gufata alectinib igihe cyose ifasha kugenzura kanseri yawe kandi ingaruka zikomeza kuba zicungwa. Ibi bishobora kuba amezi cyangwa imyaka - uko umuntu ameze biratandukanye.
Muganga wawe azagenzura iterambere ryawe hamwe n'ibizamini bisanzwe n'ibizamini by'amaraso kugirango arebe uko umuti ukora neza. Bazashaka ibimenyetso byerekana ko ibibyimba bigabanuka cyangwa biguma bihamye.
Kimwe n'indi miti yose, alectinib ishobora gutera ingaruka, nubwo atari buri wese uzigira. Ingaruka nyinshi zirashoboka kuzitaho, kandi itsinda ry'abaganga rizabafasha guhangana n'izigaragaza.
Dore ingaruka zisanzwe ushobora guhura nazo, dukurikije uko zikunda kugaragara:
Inyinshi muri izi ngaruka zoroheje cyangwa ziciriritse kandi akenshi ziragenda zikira uko umubiri wawe umenyera umuti. Muganga wawe ashobora gutanga ibitekerezo byo kuzitaho neza.
Ingaruka zimwe zitagaragara cyane ariko zikomeye zisaba ubufasha bwihuse bw'abaganga. Izi zirimo kugorana guhumeka, urubavu rukomeye mu mitsi, impinduka zikomeye mu mboni, cyangwa ibimenyetso by'ibibazo by'umwijima nk'uruhu cyangwa amaso y'umuhondo.
Gahoro cyane, alectinib ishobora gutera umuvumo ukomeye mu muhogo cyangwa kwangirika gukomeye kw'umwijima. Muganga wawe azakugenzura neza akoresheje ibizamini by'amaraso bya buri gihe kugirango amenye ibibazo byose hakiri kare.
Alectinib ntabwo ikwiriye kuri buri wese. Ntugomba gufata uyu muti niba waragize allergie ikomeye kuri wo mu gihe cyashize cyangwa niba kanseri yawe idafite ihinduka rya ALK mu mikorere y'uturemangingo.
Bwira muganga wawe ibijyanye n'uburwayi bwawe bwose mbere yo gutangira gufata alectinib. Ibi ni ngombwa cyane niba ufite ibibazo by'umwijima, indwara y'ibihaha, cyangwa ibibazo by'imboni, kuko umuti ushobora gutuma izi ndwara zirushaho kuba mbi.
Niba utwite, uteganya kuzabyara, cyangwa uri konjesha, biganireho na muganga wawe. Alectinib ishobora gukomeretsa umwana utaravuka, bityo gukoresha uburyo bwo kuboneza urubyaro neza ni ingenzi mugihe uvurwa.
Muganga wawe azareba kandi imiti yose ukoresha kugirango arebe niba hari iyo ihura. Imwe mumiti ishobora kugira ingaruka kumikorere ya alectinib cyangwa ikongera ibyago byo kugira ingaruka ziterwa n'iyo miti.
Alectinib igurishwa ku izina rya Alecensa mumihanda myinshi, harimo na Leta Zunze Ubumwe z'Amerika. Iri n'izina risanzwe ubona ku icupa ry'umuti wawe.
Uyu muti ukorwa na Roche/Genentech, kandi ushobora kubona izina ryabo ku ipaki hamwe n'izina rya Alecensa.
Imiti ya alectinib idafite izina ry'ubucuruzi ntiriboneka cyane, bityo abantu benshi bakoresha uwo ufite izina ry'ubucuruzi. Ubwishingizi bwawe bushobora kuba bufite ibisabwa byihariye byo gutanga uyu muti.
Niba alectinib itagukwiriye cyangwa ikareka gukora, hari ubundi buryo bwo kuvura bwibanda ku ndwara ya kanseri y'ibihaha ya ALK-positive. Muganga wawe ashobora gutekereza crizotinib, ceritinib, cyangwa brigatinib nk'uburyo bwo gusimbuza.
Buri muti muri iyi miti ukora mu buryo butandukanye kandi ufite uburyo bwe bw'ingaruka. Muganga wawe azahitamo uburyo bwiza bushingiye ku miterere yawe, harimo n'ubuvuzi wabanje kugerageza.
Mu bihe bimwe na bimwe, muganga wawe ashobora kugusaba gukoresha imiti gakondo ya chemotherapy cyangwa immunotherapy aho gukoresha uburyo bwo kuvura bwibanda ku ndwara. Icyemezo gishingiye ku bintu byinshi, harimo n'uburyo kanseri yawe yitwayeho kubuvuzi bwa mbere.
Ubushakashatsi bwa kliniki buvuga ko alectinib ishobora kuba ifite akamaro kurusha crizotinib, cyane cyane mugukumira kanseri gukwirakwira mu bwonko. Alectinib kandi ikunda gutera ingaruka nke zikomeye kurusha crizotinib.
Abaganga benshi ubu bakunda gukoresha alectinib nk'umuti wa mbere wo kuvura kanseri y'ibihaha ya ALK-positive ikimara kuvumburwa. Ariko, imiti yombi irakora, kandi muganga wawe azahitamo bitewe n'uko ubuzima bwawe bumeze.
Umuti "mwiza" biterwa n'ibyo ukeneye byihariye, izindi ndwara ufite, n'uko umubiri wawe witwara ku miti. Ibyiza ku muntu umwe ntibishobora kuba byiza ku wundi.
Alectinib muri rusange ifatwa nk'umuti ukwiriye abantu bafite indwara z'umutima, ariko muganga wawe azakugenzura neza. Bitandukanye n'indi miti imwe ya kanseri, alectinib ntikunze gutera ibibazo bikomeye by'umutima.
Ariko, niba ufite amateka y'indwara z'umutima, muganga wawe ashobora gushaka kureba imikorere y'umutima wawe mbere yo gutangira kuvurwa kandi rimwe na rimwe mugihe cyo kuvurwa. Bashobora kandi guhindura urugero rw'umuti niba bibaye ngombwa.
Niba unyweye alectinib nyinshi bitunguranye kuruta uko byategetswe, vugana na muganga wawe cyangwa ikigo gishinzwe kugenzura uburozi ako kanya. Ntukegere ngo urebe niba ibimenyetso bigaragara - ni byiza kubona inama z'ubuvuzi ako kanya.
Kunywa alectinib nyinshi bishobora kongera ibyago byo kugira ingaruka zikomeye. Itsinda ry'ubuzima rishobora gushaka kukugenzura neza cyangwa gutanga ubuvuzi bwihariye bitewe n'umuti wanyweye wiyongereye.
Niba wirengagije urugero kandi hashize amasaha atarenga 6 uhereye igihe cyari giteganijwe, nywa urugero wirengagije hamwe n'ibiryo. Niba hashize amasaha arenga 6, reka urugero wirengagije hanyuma unywe urugero rukurikira ku gihe gisanzwe.
Ntuzigere unywa urugero ebyiri icyarimwe kugirango usubize urugero wirengagije. Ibi bishobora kongera ibyago byo kugira ingaruka zikomeye utagize akamaro kiyongereye.
Reka gukoresha alectinib gusa igihe muganga wawe abikubwiye. N'iyo wumva umeze neza, imiti irashobora kuba igikora kugirango igenzure kanseri yawe.
Muganga wawe azahitamo igihe cyo guhagarika bishingiye ku buryo kanseri yawe yitwara, ingaruka mbi urimo guhura nazo, n'ubuzima bwawe muri rusange. Bazakoresha ibizamini bya scans n'amaraso kugirango bafate iki cyemezo.
Uduce duto twa alcool muri rusange ni byiza mugihe ufata alectinib, ariko ni byiza kubiganiraho na muganga wawe mbere. Alcool rimwe na rimwe irashobora gutuma ingaruka mbi zirushaho nk'umunaniro cyangwa isesemi.
Niba unywa, guma ku bwinshi buciriritse kandi witondere uko umubiri wawe witwara. Abantu bamwe basanga alcool ibagiraho ingaruka nyinshi mugihe bari ku miti ya kanseri.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.